NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Differences between new S-3 and previous.

Adds Depository Shares to the list of possible issuance. This does not refer to ADRs, but to fractional Preferred.

As nwbo's market cap is higher, they no longer face 12 month restrictions based on float below $75m.

Adds "blue sky" registration notice.

Under business description, mentions finalizing the SAP.

There are a few changes to the "risks" section.

- removes reference to HE
- removes mention of enrollment as a risk

+ curing material weaknesses in financial reporting
+ Special Cases (UK) and RTT (US)
+ risks related to third parties (2 separate mentions)